Clinical trial
Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
NCT00302523 · Nanjing University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00302523 |
|---|---|
| Title | Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy |
| Official title | Tacrolimus Treatment of Patients With Idiopathic |
| Lead sponsor | Nanjing University School of Medicine, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Idiopathic Membranous Nephropathy |
| Intervention type | Drug |
| Interventions | Tacrolimus |
| Enrollment | 16 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Mar 14, 2006 |
| Last update posted | Feb 3, 2012 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: